PropertyValue
?:abstract
  • Estimating prevalence of SARS-CoV-2 antibodies is important to determine disease burden. We tested residual samples from 763 Seattle-area adults for SARS-CoV-2 antibodies. Prevalence rose from 0% to 1.2% between October 2019-April 2020, suggesting a small percentage of this metropolitan-area cohort had been infected with SARS-CoV-2 at that time.
is ?:annotates of
?:creator
?:doi
?:doi
  • 10.1101/2020.12.07.20244103
?:license
  • medrxiv
?:pdf_json_files
  • document_parses/pdf_json/8612e4fbb10c71c0f7cd26bf3a5c7cc14f345bb6.json
?:publication_isRelatedTo_Disease
?:sha_id
?:source
  • MedRxiv; WHO
?:title
  • Seroprevalence of SARS-CoV-2 Antibodies in Seattle, Washington: October 2019-April 2020
?:type
?:year
  • 2020-12-08

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/oap7i5ea>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/oap7i5ea>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all